<SEC-DOCUMENT>0001144204-12-060804.txt : 20121109
<SEC-HEADER>0001144204-12-060804.hdr.sgml : 20121109
<ACCEPTANCE-DATETIME>20121109152356
ACCESSION NUMBER:		0001144204-12-060804
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20121109
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121109
DATE AS OF CHANGE:		20121109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		121193365

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v328061_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 8-K</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event
reported): November 9, 2012&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center">BIOANALYTICAL SYSTEMS, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">(Exact name of registrant as specified in its charter)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 22%; border-bottom: black 1pt solid; text-align: center">Indiana</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 38%; border-bottom: black 1pt solid; text-align: center">0-23357</TD>
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 28%; border-bottom: black 1pt solid; text-align: center">35-1345024</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(State or other jurisdiction of incorporation or organization)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2701 KENT AVENUE</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WEST LAFAYETTE, INDIANA</P></TD>
    <TD STYLE="width: 11%">&nbsp;</TD>
    <TD STYLE="width: 42%; border-bottom: black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">47906-1382</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">(Address of principal executive offices)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Registrant's telephone number, including
area code: (765) 463-4527</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act(17CFR240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act(17CFR240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&#168;</FONT>
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act(17CFR240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 1.01 Entry in a Material Definitive
Agreement</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 9, 2012, Bioanalytical Systems,
Inc. (the &quot;Company&quot;) and Regions Bank (&ldquo;Regions&rdquo;) executed a Sixth Amendment (&ldquo;Amendment&rdquo;) to
its loan agreement with Regions. Regions agreed to extend the term loan maturity date to May 4, 2013. The unpaid principal on the
notes will be incorporated into a replacement note that will bear interest at LIBOR plus 400 basis points (minimum of 6.0%) with
monthly principal amortization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing discussion of the Amendment
is entirely qualified by reference to the text of the Amendment, which is attached as Exhibit 10.1, and incorporated herein by
this reference.&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On November 9, 2012, the Company issued
a press release announcing the Amendment. The full text of the press release is furnished as Exhibit 99.1 to this Form 8-K and
is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B>Item 9.01 Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;Exhibits:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.1</TD><TD>Sixth Amendment to Loan Agreement between Bioanalytical Systems, Inc. and Regions Bank, executed November 9, 2012.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">99.1</TD><TD>Bioanalytical Systems, Inc. press release, issued November 9, 2012.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">Bioanalytical
Systems, Inc. </FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Date: November 9, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Jacqueline M. Lemke</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Jacqueline M. Lemke<BR>Interim President and Chief Executive Officer and <BR>
Chief Financial Officer and Vice President&mdash;Finance</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>v328061_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Sixth
Amendment To Loan Agreement</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Sixth Amendment
to Loan Agreement (&ldquo;Amendment&rdquo;) is dated effective as of November 1, 2012, and is between Regions Bank, an Alabama
banking corporation, as successor by merger to Union Planters Bank, N.A. (&ldquo;Lender&rdquo;) and Bioanalytical Systems, Inc.,
an Indiana corporation (&ldquo;Borrower&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-variant: small-caps"><B>Recitals</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lender, Borrower and
BAS Evansville, Inc. (&ldquo;BAS&rdquo;) entered into a certain Loan Agreement dated October 29, 2002, as amended by a certain
Amendment to Loan Agreement dated June 1, 2004 and a certain First Amendment to Loan Agreement dated February 11, 2008 (collectively,
the &ldquo;Prior Loan Agreement&rdquo;) in connection with (i) a certain Promissory Note (Term Loan) executed by Borrower in favor
of Lender in the original principal amount of $5,410,000.00 dated October 29, 2002, as amended by Amendment to Promissory Note
(Term Loan) dated June 1, 2004, (ii) a certain Promissory Note (Loan (West Lafayette)) executed by Borrower in favor of Lender
in the original principal amount of $2,250,000.00 dated October 29, 2002, as amended by Amendment to Promissory Note (Loan (West
Lafayette)) dated June 1, 2004, and (iii) a certain First Replacement Promissory Note (Loan (Mt. Vernon)) executed by Borrower
and BAS in favor of Lender in the original principal amount of $1,698,540.11 dated February 11, 2008 (&ldquo;Mt. Vernon Note&rdquo;)
(all notes listed in this recital are collectively, the &ldquo;Prior Notes&rdquo;). As security for the Prior Loan Agreement and
the Prior Notes, Borrower granted to Lender a certain Real Estate Mortgage and Security Agreement (Fixture Filing) (West Lafayette)
dated October 29, 2002, and recorded on November 19, 2002, as Instrument No. 02037358 with the Office of the Recorder of Tippecanoe
County, Indiana, and BAS Evansville, Inc. granted to Lender a certain Real Estate Mortgage and Security Agreement (Fixture Filing)
(Mt. Vernon) dated October 29, 2002, and recorded on November 13, 2002, as Instrument No. 20027318 with the Office of the Recorder
of Posey County, Indiana (collectively, the &ldquo;Prior Mortgages&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Lender and Borrower
entered into a certain Loan Agreement dated December 18, 2007, as amended by a certain First Amendment to Loan Agreement dated
January 3, 2008, a certain Second Amendment to Loan Agreement dated May 18, 2009, a certain Third Amendment to Loan Agreement dated
January 13, 2010, a certain Fourth Amendment to Loan Agreement dated November 29, 2010 and a certain Fifth Amendment to Loan Agreement
dated effective as of February 11, 2011 (as the same may be further amended from time to time, collectively, the &ldquo;Loan Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To further secure the
Indebtedness of Borrower to Lender, BAS executed and delivered to Lender a certain Unconditional Unlimited Continuing Guaranty
dated January 13, 2010 whereby BAS guarantied the Indebtedness of Borrower to Lender (the &ldquo;Guaranty&rdquo;). (The Prior Loan
Agreement, the Prior Mortgages, the Loan Agreement and the Guaranty, together with any and all promissory notes and any other commercial
documents and agreements executed in connection therewith collectively are the &ldquo;Loan Documents.&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties desire
to amend the Loan Agreement to modify certain terms of the Loan Agreement, as herein provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Terms</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in
consideration of the foregoing and the mutual obligations of the parties hereto, the Loan Agreement is hereby amended as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-variant: small-caps">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Amendments
to the Loan Agreement.</B></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">A. &#9;<B>Section
1 (Definitions) </B>the definition of <B>&ldquo;Term Loan Maturity Date&rdquo; </B>is amended to mean May 4, 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">B.&#9;<B>&nbsp;&nbsp;Section
2 (Term Loan)</B>. Section 2 (Term Loan) is amended to read: Lender shall lend to Borrower and Borrower shall borrow from Lender
the amount of <FONT STYLE="font-size: 10pt">$5,786,496.72 </FONT>pursuant to the terms and conditions in the Loan Agreement and
in that certain Replacement Term Loan Note dated effective November 1, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">C.&nbsp;&nbsp;&#9;<B>Section
5 (Fees and Expenses)</B>. Section 5 is amended to provide that Borrower shall pay to Lender a non-refundable commitment fee in
the amount of $15,000.00 in connection with this Amendment, payable in full upon execution of this Amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9;2.&#9;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Continuing
Effect.</B></FONT> All other terms, conditions, representations, warranties and covenants contained in the Loan Agreement shall
remain the same and shall continue in full force and effect. In consideration hereof, Borrower represents and warrants that each
representation and warranty set forth in the Loan Agreement, as hereby amended, remains true and correct as of the date hereof,
except to the extent that such representation and warranty is expressly intended to apply solely to an earlier date, that there
presently exist no known offsets, counterclaims or defenses to the performance of the obligations under the Instruments (collectively,
the &ldquo;Obligations&rdquo;) (such known offsets, counterclaims or defenses, if any, being hereby expressly waived), and that
Borrower has no other known claims, demands, allegations or rights of action of any nature based on any matter arising from or
related to the Obligations or Borrower&rsquo;s relationship with the Lender (such known claims, demands, allegations or rights
of action, if any, being hereby expressly waived) nor has there occurred any Event of Default under the Loan Agreement or any of
the Instruments, and that there will be no Event of Default after giving effect to the transactions contemplated by this Amendment.
The representations and warranties contained in the Loan Agreement originally shall survive this Amendment in their original form
and shall survive as continuing representations and warranties of Borrower. Except as expressly herein provided, the Loan Agreement
and this Amendment shall be interpreted, wherever possible, in a manner consistent with one another, but in the event of any irreconcilable
inconsistency, this Amendment shall control. The parties each hereby agree to cooperate in all reasonable requests of each other
party hereto, including, without limitation, the authentication of financing statements and other documents, which the requesting
party deems reasonable, necessary, appropriate or expedient to carry out the intents and purposes of this Amendment. Capitalized
terms used herein and not specifically herein defined shall have the meanings ascribed in the Loan Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9;3.&#9;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Conditions
Precedent.</B></FONT> Notwithstanding anything contained in this Amendment to the contrary, the Lender shall have no obligation
under this Amendment until each of the following conditions precedent have been fulfilled to the satisfaction of the Lender:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a)&#9;The Lender shall have
received each of the following, in form and substance satisfactory to the Lender:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(1)&#9;This
Amendment and such other instruments, documents and opinions as the Lender shall reasonably require, all duly executed by the parties
thereto in the forms approved by the Lender;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(2)&#9;The
Replacement Term Loan Note dated effective as of November 1, 2012 executed by the Borrower;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(3)&#9;A
Consent and Confirmation of Guaranty executed by BAS;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(4)&#9;All
reasonable expenses of the Lender (including, without limitation, reasonable attorneys&rsquo; fees), shall have been reimbursed
by Borrower.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(b)&#9;All legal matters incident
to this Amendment shall be reasonably satisfactory to the Lender and its counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9;4.&#9;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-variant: small-caps"><B>Counterparts.</B></FONT>
This Amendment may be executed in one or more counterparts, each of which shall be deemed an original but all of which together
will constitute one and the same instrument. Facsimile signatures will be deemed acceptable and binding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The parties are signing
this Amendment effective as of the date stated in the introductory paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top; text-align: left; text-indent: 1.32in">LENDER:</TD>
    <TD COLSPAN="2"></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">REGIONS BANK</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Michael F.
Zingraf, Senior Vice President<BR></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt"></P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top; text-align: left; text-indent: 1.32in">BORROWER::</TD>
    <TD COLSPAN="2"></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">BIOANALYTICAL SYSTEMS, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Jacqueline
M. Lemke<BR>
CFO, Vice
President of Finance<BR></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">STATE OF INDIANA</TD>
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">)</TD>
    <TD STYLE="width: 63%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">SS:</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">COUNTY OF ___________</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">)</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Before me, the undersigned
Notary Public, personally appeared Jacqueline Lemke, the Vice President of Finance and Administration of Bioanalytical Systems,
Inc., an Indiana corporation, who on behalf of said entity acknowledged the execution of the foregoing instrument and swore to
the truth of the statements made therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Witness my hand and
Notarial Seal this _____ day of November, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">My commission expires:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________</P></TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notary Public</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">County of Residence:</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">___________________</P></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">_______________________________________</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Printed</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>v328061_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><IMG SRC="image_004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 58%; text-align: right">FOR MORE INFORMATION:</TD>
    <TD STYLE="width: 42%; font-weight: bold; text-align: right">Company Contact:&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Jacqueline Lemke&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Interim President &amp; CEO and CFO&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Phone:&nbsp;&nbsp;765.497.5829&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">jlemke@BASinc.com&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right"><B>Agency Contact:</B>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Neil Berkman&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Berkman Associates&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">Phone:&nbsp;&nbsp;310.477.3118&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: right">info@berkmanassociates.com&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>BASi
Announces Extension of Mortgage Maturity</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">WEST LAFAYETTE,
IN &ndash; November 9, 2012 -- <B>Bioanalytical Systems, Inc. (NASDAQ:BASI)</B> announced today that it has negotiated a six month
extension, until May 2013, on the maturity of its $5,787,000 mortgage that was originally scheduled to mature this month.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&quot;This
extension enhances our flexibility as we complete BASi's restructuring and build a healthy business model for the future,&quot;
said Interim President &amp; CEO and CFO Jacqueline Lemke.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&quot;The
streamlining of our locations has improved capacity utilization while allowing us to continue providing the high quality services
and instruments our clients expect from BASi. We are focused on taking advantage of our competitive strengths &ndash; specialty
assay and discovery capabilities, a long history of regulatory excellence, and our market-changing Culex&reg; automated in vivo
sampling system &ndash; and we are optimistic about the outlook for fiscal 2013.&quot;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">BASi expects
to announce audited financial results for fiscal 2012 on December 20, 2012.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify"><B>About Bioanalytical Systems,
Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">BASi is
a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug
development companies and medical research organizations. The company focuses on developing innovative services and products that
increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: justify; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: center; text-indent: 16.55pt"><I>This
release contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and
uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of
products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks
detailed in the company's filings with the Securities and Exchange Commission.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: center; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.3in 0pt 0; text-align: center; text-indent: 16.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right">&nbsp;<IMG SRC="image_003.jpg" ALT=""></P>



<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``H`S`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"BBB@`HHHH`****`"BBB@`JA)J#RRM#80B>13M>1FVQ(?0MW/L,^^*9>2/=W
M+6,4ACB0!KJ53@@'H@/8GJ3V'U!KSSQ-XU>4G3=$;[-8Q_)YD7RE_IZ+_.N?
M$XJ&'AS3.G"X6IB9\L/O.UO=1M[)\:EXB2"0=88%1<?@0S?J*S3XE\-ACGQ%
M?9SV$G_Q%>3DDDDG)-%>++.:M_=BOZ^X]R&24DO>DW]R_P`SU?\`X27PW_T,
M-_\`E)_\11_PDOAO_H8;_P#*3_XBO***C^V:_9?C_F5_8N'[O\/\CU?_`(27
MPW_T,-_^4G_Q%'_"2^&_^AAO_P`I/_B*\HHH_MFOV7X_YA_8N'[O\/\`(]7_
M`.$E\-_]##?_`)2?_$4?\)+X;_Z&&_\`RD_^(KRBBC^V:_9?C_F']BX?N_P_
MR/5_^$E\-_\`0PW_`.4G_P`11_PDOAO_`*&&_P#RD_\`B*\HHH_MFOV7X_YA
M_8N'[O\`#_(]7_X27PW_`-##?_E)_P#$4?\`"2^&_P#H8;_\I/\`XBO***/[
M9K]E^/\`F']BX?N_P_R/5_\`A)?#?_0PW_Y2?_$4?\)+X;_Z&&__`"D_^(KR
MBBC^V:_9?C_F']BX?N_P_P`CU?\`X27PW_T,-_\`E)_\11_PDOAO_H8;_P#*
M3_XBO***/[9K]E^/^8?V+A^[_#_(]7_X27PW_P!##?\`Y2?_`!%'_"2^&_\`
MH8;_`/*3_P"(KRBBC^V:_9?C_F']BX?N_P`/\CU?_A)?#?\`T,-_^4G_`,11
M_P`)+X;_`.AAO_RD_P#B*\HHH_MFOV7X_P"8?V+A^[_#_(]7_P"$E\-_]##?
M_E)_\11_PDOAO_H8;_\`*3_XBO***/[9K]E^/^8?V+A^[_#_`"/5_P#A)?#?
M_0PW_P"4G_Q%'_"2^&_^AAO_`,I/_B*\HHH_MFOV7X_YA_8N'[O\/\CU?_A)
M?#?_`$,-_P#E)_\`$4?\)+X;_P"AAO\`\I/_`(BO***/[9K]E^/^8?V+A^[_
M``_R/5_^$E\-_P#0PW_Y2?\`Q%'_``DOAO\`Z&&__*3_`.(KRBBC^V:_9?C_
M`)A_8N'[O\/\CU?_`(27PW_T,-_^4G_Q%'_"2^&_^AAO_P`I/_B*\HHH_MFO
MV7X_YA_8N'[O\/\`(]I\-WEG?7FHS6-W+=0_NAYDN<YPW'(%=#7`_"[_`(\M
M1_ZZ)_(UWU>_AZCJ4HS>[1\_B::I5I0CLF%%%%;&`4444`%%%%`!1110`444
M4`%%%%`!1110`5FZW--;6!F@N'BD!"HB*I\QV("K\P/<BM*H9[6&Z\KSDW>5
M()4Y(PPZ&@#F_P"UM02]DB>68^3+]F!6%#'+)Y(;GD,&+=,<8P.]:.DZA((+
MH:A),LULJO,)E0;5*YR-G;@]>>*M2Z-8S73W$D19GY92YV$[=N[;G&=O&:+?
M1K*VV[$D)5@VYY68G"[0"2>0`<8/%`'.0>(;Z[D>*.0L\MV%1;<1L\<9AWA1
MN^7.1@D^C5>BU*[8Z5<K>F2"Z9(V!@"+RISNZD,3C`!QVK5ET:QE9W\IHY'D
M$I>)V1@P7:""#Q\O'%,CT+3HI8WC@*^6%VH)&VY484D9P2!W-`%+4M::'Q!8
MV,,\:1^:$N`2-S%D8J`#SV'/^THJO;ZC?"UDCO[R:SN$CBFE,L<?RHV0?+P#
MDEAC#`GVYK;.EV1CMT:`,+<@Q[B200"O))R>">N:K#P[IHC">5+@%"I\]PRA
M,[0"#D`9.`*`*<<^J,=+22Z>*YN/FDA,:86->6)XR"1M'7@M[5T-5H;"WAF2
M95<RI&8E>21G;:3DC+$YY`_*K-`!6!K&IW5KJ:1PRE8D2-W`0%1NDVGS"1D#
M&<;><@YK?JC=:39WMP)YD<OA58+(RAP#D!@#@@'UH`Y[^V]0_P!'_?\`_'_]
MS*+^X_?I'QQS\K]\\C\*T&U*ZCT&ZD,NZXAN6MUDVC<_[P*,#&-Q!QTQGVJ[
M_86G_O?W3?O/^FC?)\V_Y>?E^;GCO3CHE@;?R3$^T@\^:V<[M^[.?O;N<]:`
M,"X\1W$-G#$+I%N5NL2M,%5Q$)0F".FX@]N,`FM6PO+LZL\%Z9T$IF,"LJ;&
M57P""/FSM*GGU-7!H]B+7[.T.]#()"78EF8,&R6SD\@4Q=#L%DD<1OE]W'FM
MA=QW-M&?ER1DXH`R_P"VY[O6[RVM[VVA@2W<1E\'#JP#,>_'S8'3C-5;K7[R
MVTS:+H++)*SP3S*JLT"E?F*X`R2<#CISVKHKK2;&\,AGMPQDC,3$,5RI.2.#
MZBC^RK0VKVSI)+$QR?.F>0]NC,20..F:`,K3]7GNM:*/)*L#SS0QKY2&-MGH
MP.X'@GD8/:NBJE%I-G#>F[2-A*26`WG:K$8)"YP"<=:NT`%%%%`&%=ZY):WF
MH(P'EVJ;@OD.=YV;@#)G:O/&#3$UZY9M/39;E[MWA)5N%='PQZ\C`./?'K6O
M)I]K*9M\6[SG1Y/F/S%<;?Y#COWJ$Z+IYD>3[/\`,[!B0[#!#!LCGCD`\8Z4
M`0ZY)=0P1M:73Q32.(8D"*0SL>IR#P!DG'8&LAM8U)Y[I8FG\S=<06Z>2A1W
MC!Q@YW;N">1@].U=-+:PSS02R)N>!B\9R?E)!&<=^":J2:%I\LLTDD);S=VY
M3(VT%AAB!G`)]10!#9ZF(;"^EO))]]HY\T3*@9?E#`#9P<@C\ZPTUW4I;-G:
MZ(VRS[Y+:(2["H!C3@'@Y;GOCJ*Z:#2K2W(*([,&+EGD9BQ(`);)YX`'/3%1
MRZ'82J1Y3)N=G)CD922PPW0]".U`%*RN[V[U"RVW3;)+87,\11=J!AA5!QGD
MY/7HI]:MM<W8\1"UWQ_9VM7D1=O.X,HR3^)Z8ZU:&GVJM.RQ;3/&L<FUB,JH
M(`'/&,GI3DLX$GCF5#YD<7DJQ8G"9!Q^@YZT`84>HZA<1V]NUR(YI+NYC>6.
M,<+'OP`#D=AUSQGZTEEJ=_>3Z9(LX8W$:22VR1C;'&4^9V.,@ENG/(['DUKR
MZ192P^48W4"5I@R2,K!VSN((.1G<>/>DAT:QM[D7$"2Q/A1A)W5"%&U05!VG
M`'I0!?HHHH`KWUP]II]Q<I%YK0QM((]V-V!G&:PW\6#]_P"39&01>8P_>XW1
MHI)8<?W@5Q71LH=2K#*D8(/>J%OH>FVK*8;4*5@-N"68_NR<E>3Z]^M9351O
MW6:TY4TO?5V9C^*@#/LL]PA:4D^;C,2;<R=/]KI[=:M:=KW]HZ@]JML4V-*"
MQ?/RKLVMT_BW_A@U9BT/38%98[8`-;_9CEF.8_[O)]^O6B+1-.@=7BM]C*L:
M`B1LXC.5'7_]??-2HUKZO^ON+<J-G9?U]YSEGX@O8(6N;RXE>,VL\H$L:*I9
M'P`A4#MUW>HQ4L.KZA<:9"4O6G,,LL=S<6:1R,V!E&"X((PRYVC-;2>'-+08
M^SNR@Y57F=@OS!OE!;C)`)QU[U)<Z+8W4[3NDB3,<F2*5D8_*%Z@^@`_`>E9
MJE52U?XLT=:BWI'\$8T'B"[$KQH8KTR%!$^?*3'V<2$]"<$YX/3-:.G:U-J4
ML;168%L=JNYE&Y6:(2?=QR,,!USGMBK":)IT3JZ6P4KTPS`#Y/+Z9_N\5'_P
MCVFY&(7"A`@42N!PFP'K][;QGKBK4:JZ_P!?<0YT7TZ?UU*\VO31BYF6S5[:
M.1H4?S<,9`P7!&.`6/49Z>]5YO$\\7FH+!&E@61I@)L#Y'53M^7G.X$9Q6G)
MH>GRS32O"S&4-N!D;`)QD@9P"<#D<\4#0]/",IA9MR,C,TC$L&8,V3GDD@<T
MW&KT?]?<)2HK=?U]Y)IM[)>QS^;$L4D$S0L$?<#C!R#@=B.U7:B@MH;8RF)-
MIED,C\DY8XR?T%2UM&Z6IA)IO0****8@HHHH`****`"F2R+#$\KG"(I9C["G
MU0UOG0K\>MO(/S4T`<EXMU*73/"<40;;=ZFQ>4]P",L/P!5?I7F-=[\4"?M^
MG)_"(F('XC_"N"KY7-*CEB6GTL?6Y334<,FMW<*Z2VCT]/"S7-Q8QJX^6*5V
M.^>7>#@`'[@7@^_O7-U?.LWS::FGL\;6R*553`A*@G)PV-PY]ZY*4XPNY=CL
MK0E.RCW[V.DCMK!_*>32[5)X],EOFC3?L)/^K!!8GH,]?XJBOM-TJ&3Q!%%:
M.LUO$DD1+Y1`2G`'7/S'DGI6%'KFH)??;/.5IC%Y+;HU*LF-NTKC!&!Z5'+J
MU]-->2R3Y>\7;.=H^89!QTXZ#IZ5T/$4G&W+KZ+M;_(YUAZJE?FT]7W3_P`S
MHO"NCVFH:1<W,]NDTMO/O6,G!E`C8^6/J0/P!JLOAN&72;>^DNUCFN2CB(;0
M,-)LPJYW9'7ICM6-::M?6$:QVLYC59EG&%!^<`@'D>A/'2I_^$AU+[*+?SD"
M!@P(B7=P^\#..F[G'2E&K0Y%&4=4G]XY4:_.Y1EHVON-F3P[IUI'>,TTT^RV
MG*$H%VR1R!,\-R/K1X5T*/4M(U"62U,SR$PPN`3Y3"-FW?GL'XUB?V]J)+EI
MU?>LB,&C4@B0[F[=SS[=JBM]6OK1+98)]@MI3-$`J_*YQD].>@ZT*M04U+ET
M["=&NZ;CS:OK_7R-RV\(QW!LV^V,$NMI3Y`#CRFD?J<<$;?QJ2#PE937DD7]
MHN4\V**,QJK_`#2*3AB&QP1@XS6(NOZDIM,7/%H6,*[%PN[[W&.0>F#VI_\`
MPD>J>>9EN%1MZ2`+$H"E!A<#&``#TZ4U4PRM>+_I>O<'2Q3O::_I^G8O6_A=
M;B&%A=%6E%L0"G`,SE?7MBJ6O:5!I-S%'!<B970D@LI9""1@[21V!_&F#Q!J
M2VL-NMP%2+9M*QJ&^0[ERV,G!)Q4&H:G=:I*DERR'8NU%1`BJ,DG```ZDFLY
MRH.%HK7^O,TA"NJEY/3^O(IUV'AG2]/U&RM);F%,0W,D<Y_O*R#9GZ,:X^K=
MMJ=Y9VLUM;S%(IBK2+M!R5.1R1D<^E10J1A.\U=%XBG*I"T'9G5?\(M:7+1Q
M2RK:?9K:!9V!49DDW-N8L1P!C@<U6TOP[I\C:7-+-+<QSSK%*$4;`22-I(.5
M/`ZXR#Q65'XFU6.]N+O[0K3SE2[/$A&5&%(&,`CL134\2:I'#!$MPH$+(RMY
M:[CM)*@G&2!DX!]:Z/;8:Z?+_5].O8YO8XJS7-_5M>G?8DL;2VD@UPF,,((=
MT);JO[Q1GZX-26F@PW&@2ZB\TR/&ADV[%VLH<*0,G)Z]<8'2J%KJ]Y97%Q-;
MO&C7`(D!B1E()SC:01UJ5]?U%[.2U,L8BD#!@L"`X8[BH('`SS@5E&=&WO+H
M_P`].IM*%:_NOJONMKT.AU#PS97.H:K]G,ENEL66)0@V?)&&(R6R2>>G3J:K
M1^$(GFA!O&\J8-)&=H!>,1+(3R<#E@O)QU-97_"3:MMN`;A29V9W8PH3EEVM
MCCC(P./2I+CQ'<$Z=]E!C%E;F`>9B0/G(;((Q@@XQZ"MG4PLFY<O7]?\C%4L
M5%**ET_3T[FYI_AS2!>);S,UT/MZ0[T;AD:(MMRK8Z]2/2LJ]\/6]KH0U`7?
M[QU$B1,5&Y2Y7`&[=D8R3C'Y547Q)JBSM.)U\QIDFSY:\,HVC''`QQCTJ.37
M;^6R^QO(GD9!PL2@X#%@N<9V@DD#I4RJX=Q:Y>]OTZE1I8E23YNU_P!>A+X:
MMH;O65BN(UDC\F5MK=,B-B/U%;]QHMA_PCYO8X$$B:6C2#TD)0A_J07'_`:Y
M;^U;E-4EU"`K#-(7^ZHP`P((QC'0FG'6M0,$D'V@^7)"ENR[5Y1?NCIV]>M3
M2JTH0<9*^^OY%5:-6<U.+MMI^9LZ'H27/A[4KZ:TDE<P.;=@IPI3;D\=SNX'
M^RU6+2'3+@:2+O3[."6Y\V8!6=5954A%;<Q^\X/IT'K7,6U_=6:3)!,R+-&8
MI!P05)!(YZ=!R*D75KU;FVN/-!DMHQ%%N12`@SQC&#U/7UHA7IQ45R^NW>X3
MH59.3YM]M^UCN(=`TQ;J/S+&%OM4EO&Z!R5CWQ,S;"#ZC@Y-8VJZ3:0>&XWM
MX[?S8X()I6._S<R9YS]TCMCMBLN/Q1JT4\LJ7"!I-O'E)A"HVJ5&,+@<<57F
MUJ^GTY;"24&!0J_<`8A<E06QD@9.!6D\10<6E'OT7R,H8;$*2;EVZOYF?113
MHXWED6.-2[L<*JC))]*X$FW9'H-I*[/2_A>C#3K]R/E:50#[@'/\Q7>UC^%]
M'_L/0H+1L><?WDN/[Y_P&!^%;%?:8>FZ=*,'T1\/B:BJ5I36S84445L8A111
M0`4444`%%%%`!1110`4444`9_P#:\7_/K??^`C_X4?VO%_SZWW_@(_\`A110
M`?VO%_SZWW_@(_\`A1_:\7_/K??^`C_X444`']KQ?\^M]_X"/_A1_:\7_/K?
M?^`C_P"%%%`!_:\7_/K??^`C_P"%']KQ?\^M]_X"/_A110`?VO%_SZWW_@(_
M^%']KQ?\^M]_X"/_`(444`']KQ?\^M]_X"/_`(4?VO%_SZWW_@(_^%%%`!_:
M\7_/K??^`C_X4?VO%_SZWW_@(_\`A110`?VO%_SZWW_@(_\`A1_:\7_/K??^
M`C_X444`']KQ?\^M]_X"/_A1_:\7_/K??^`C_P"%%%`!_:\7_/K??^`C_P"%
M']KQ?\^M]_X"/_A110`?VO%_SZWW_@(_^%']KQ?\^M]_X"/_`(444`']KQ?\
M^M]_X"/_`(4?VO%_SZWW_@(_^%%%`!_:\7_/K??^`C_X4?VO%_SZWW_@(_\`
MA110`?VO%_SZWW_@(_\`A1_:\7_/K??^`C_X444`']KQ?\^M]_X"/_A1_:\7
M_/K??^`C_P"%%%`!_:\7_/K??^`C_P"%']KQ?\^M]_X"/_A110`?VO%_SZWW
M_@(_^%']KQ?\^M]_X"/_`(444`']KQ?\^M]_X"/_`(4?VO%_SZWW_@(_^%%%
M`!_:\7_/K??^`C_X4?VO%_SZWW_@(_\`A110`?VO%_SZWW_@(_\`A1_:\7_/
MK??^`C_X444`']KQ?\^M]_X"/_A1_:\7_/K??^`C_P"%%%`!_:\7_/K??^`C
M_P"%']KQ?\^M]_X"/_A110`?VO%_SZWW_@(_^%']KQ?\^M]_X"/_`(444`']
MKQ?\^M]_X"/_`(4?VO%_SZWW_@(_^%%%`!_:\7_/K??^`C_X4?VO%_SZWW_@
M(_\`A110`?VO%_SZWW_@(_\`A1_:\7_/K??^`C_X444`']KQ?\^M]_X"/_A1
M_:\7_/K??^`C_P"%%%`!_:\7_/K??^`C_P"%5-3U%;C2[J&*TOB\D3*H^ROR
M2/I110!R/CJTO=;O;22QTZ]D6.,JQ-NPP<^XKD_^$9US_H$WG_?EJ**\ZOEM
M&M4=23=W_78]*AF=:C35.*5E_7</^$9US_H$WG_?EJ/^$9US_H$WG_?EJ**R
M_LBAW?\`7R-O[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?
M]?(/[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'
M9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X
M1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/^@3>
M?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/^@3>?]^6H_X1
MG7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?
M]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_L
MBAW?]?(/[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/
M[9Q'9?<_\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_
M\P_X1G7/^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/
M^@3>?]^6H_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\P_X1G7/^@3>?]^6
MH_X1G7/^@3>?]^6HHH_LBAW?]?(/[9Q'9?<_\RS9^#=>O)`HT^2(9Y:;Y`/S
M_I7H7ACP5;:$PNKAUN+W'#8^6/\`W?\`&BBNG#X"A0?-%7?F<N(S"O77+)V7
B9'54445VG"%%%%`!1110`4444`%%%%`!1110`4444`?_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X``02D9)1@`!`0```0`!``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+#`Q-#0T'R<Y/3@R/"XS-#+_
MVP!#`0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P``1"``K`S`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#W^H+J]M+)
M0UW=0P*>AED"@_G4_:O`=4U*YU;4);RZ<L[G@$\*.P'L*X<=C%AHK2[9WX#!
M/%2>MDCWJ&>&YB$L$J2QGHR,&!_$5)7D.@:)XLL@FHZ9;O&K#.UW51(/=2>1
M_D5Z1H>N1ZO"Z21-;7T/%Q;/PR'U]P?6JPV*=56G%Q?GU]"<5A%1;<)*2\NG
MJ:U%<[%J-QHVLKIVISF:VNV)M+I\`AL\QM^?!_R.BKL.(P-7\5P:&W^G:;J"
MQEBJ2JB,C?0[^_7!P:I6GQ`T^_F\FTT[4YY,;ML<2$X]?O4OQ$'_`!2C^TR?
MSKD/AM_R-#_]>S_S6O*K8BM#%1HIZ/R/7H8:C/"2KN.J\SL;OQU9V#*+W2]6
MM@QP#+;JH/\`X]S6GI/B72=:;9970:4#)B<%6_(]?PIWB.&WG\.:@MRJF,0.
MV6[$`D$>^<5XKI)N!K%G]DW?:/.7R]O7.:,1BZN&JQB_>3^\,-A*.*HRDO=:
M^X]^KG/$7C"T\.W45M)!)/*Z;R$(&T9P,Y]>?RKH99$AB>61@J(I9F/0`=37
MD.NV%WJVF3^*GW;);DHL9'W8A\JG\QBNC'5YTJ?[K??Y+=G-@*%.K4_>_#M\
MWLCU/2=3AUC3(+Z#(249VGJIZ$'\:GNKN"QM9+FYE6*&,99VZ"O._AIK'EW$
M^D2M\LG[V')_B'WA^(Y_`U?^)\DRZ78HI(A:8[\="0./ZU,,;?">WZI?B5/`
MVQ?L+V3?X&Q;^);W4T,VDZ'-<VV<+--,L(?_`'<Y)JEJ/CF32/W>HZ'=03D9
M0>8K(W_`Q_A4/@[Q?ITNFVVFW4BVUS"@C4N<)(!P,'L?8UU&KZ7;ZUIDME<`
M%''RMC)1NS"G"4ZU+GI5-?E:_P"83C3HUN2K3T]7>WY?@237\-MIC7\^4B2+
MS6QR0,9Q7,:+\0+35M52Q>SDM_-.V)RX;)[`C''ZUT\]A#=:8]A/EH7B\ML<
M'&,9KEM%^']KI&K1WLM\UQY;9BC,83![9.3G'X5=?ZS[2'LOAZ_U_D9T/JWL
MY^UOS=/Z_P`SLZ***ZSC"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`&R/LC9\9V@G%4]'U
M'^UM(MK_`,KRO.7=LW;L<XZX%6KC_CVE_P!P_P`JQ_!__(I:=_UR_J:S<G[1
M1Z6?Z&BBO9N76Z_4W***\=T"^DTKQ0+X\6QN#!,W8!B>OY9_X#6AF>Q45P_B
M_P#Y'#PW_P!=U_\`1BU1\4V$6J?$*RLIV=8YH55BA`(^\>,@T`>C45R=K\/=
M)M+N&YCN+TO#(LBAG3!(.1GY:H>&Q_9_Q`UJQ/"RAI%'XAA^C&@#NZ*\KN[U
M_P#A9/VWGRDO4MRW8<;#_(UM>+U^W^+]"T[J`PD8>Q;G]$-`'<.Z1H7=E51U
M+'`%)'+',NZ*177U4Y%>?SQ+XG\?W&G:A-(+2U5O+A5L!B,#]<DY]!5M?"][
MHGBNTN=$BD.GOM%P&E&%!.&&"<GCGOS0!W%%%>;:GI=OK'Q-FLKHN(G0$[#@
M\1@T`>DT5YCX@TD>"[VQOM)N9P)&(:-VSG&..,9!STJYXYMDO?%>C6LA81S[
M8V*]0&?!Q^=`'H5%<A'\.-'BE21;F^RC!AET[?\``:I3_P#)7;;_`*YG_P!%
M-0!WE%%>7:=H%IX@\8:Y#=R3(L<\K@Q,`<^81W!H`]1HKGM%\':?H5\;NUFN
MGD*%,2LI&#CT4>E8?C5)-9U^PT2`G<L3S-CUP2,_]\_K0!WM,DECA7=+(J+Z
ML<"N:\`7OVOPQ'$3E[9VB/TZC]#C\*P-*LX?%_B;5'U:21TMSMB@#E0%W$?I
M@?B:`/14=)$#HRLIZ%3D&G5QFC^'M1T'Q:_V))#HLJG<6D4X.W(XSG(;C..A
MK$&B6VO?$'5;2Z>5(U#2`Q$`Y!4=P?6@#TZBN:TGP3INC:E'?6\]VTL8(`D=
M2O(([*/6NEH`*\JO/#T6E_$"SCN$!L+JX$D1/0Y/W#]#@?0BO5:H:OI-OK-@
MUK<`CG='(OWHV'1A[URXK#JM%=T[K_+YG5A,2Z$GV:L_\_D.U345TJR-V\$L
ML:,/,\H9*+W8CT%,6ST_4+NUU>+#RHA\N:-L;E(Z''4>QI=)&H"P\K5!&TZ,
M4\Q#D2J.C$=B?2N4USPYJVF/+=>&[B:."3+26D3XVGU4?TZCM[=&DDFT<[O!
MM)_<-^)=[;_8K2Q#`W/F^;@=54`CGZD_I6YX-UA]8T"-YFW7$)\J0G^(CH?Q
M!'ZUY%,EW/>,LRSR73GD."7)_'FO5O`^BW&CZ,QNU*3W#^88SU08P`?>J)(_
MB)_R*<G_`%V3^=<;\.P[>(IA$P20VD@5B,@'*X.*['XB$#PHX)ZS(!7(_#;_
M`)&A_P#KV?\`FM>)BO\`D84_E^I[N%_Y%U3U?Z'1>(_#_BG4K)D_M2&XC`R;
M=$\K?_//XG%8'A;Q'I&B77EW>DF"?.QKH,793T.5/3WQ^5>K,RHA9V"JHR23
M@`5X1X@N8;WQ#?W%M@Q23L4(_BYZ_CU_&GF"^K2C6@]?/7\]4&7/ZU"5"HO=
M7;3\M'\ST_Q=?FYTZTTNPD#3:JX1'4Y`BX+-],8_`FF7.O\`A2#39=#EO@L4
M<9MF40N<8XZA<$^]6?#6BM#IFCSWB$7-K;R*%8<KO(/Y@#'XFNCKOC"I.]31
M-I;J^EMMUUN>=*I3A:GJTF]G;6^^SZ6/`+2[?3-4BNK:0,T$NY&&0&`/OV(_
MG7M<]O8>)]"02KOMKE`ZD'YE/8CT(KA_B7I(BNK?58Q@3?NI?]X#Y3^(R/\`
M@-7/AQK:_8+G39WQ]G!FC_W#]X?@>?QKS<&OJ^(EA:FJ?]?D>GC7]8P\,53T
M:_K\&<]KG@35-*+2VZF\M1SOB'S*/=?\,U!H'C'4M#D2-I&N+,'#02'.!_LG
MM_*O9D=)$5T961AE64Y!%>;_`!*T_3[>2UNH0D=Y,Q$B+QO7^\1ZYXSW_"GB
ML%]63KT)6MT%A<=]::P^(C>_7^OS1TVL0P:]X<?4K2]NX@+=I(S#,R@X!.&4
M'!YX/>O/O`\CR^-;!I'9V/F<L<G_`%;5W.B64VG_``ZDBN5*2&VFD*MP5!#$
M9_"N#\"D#QGI^?\`II_Z+:EBFW6H2:LW:_WH>$25#$03NE>WW,]HHHHKW3P`
MHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"B
MBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@".X_X]I?]P_RK'\'_`/(I:=_UR_J:V+C_`(]I
M?]P_RK'\'_\`(I:=_P!<OZFLG_%7H_S1LOX,O5?DS<KRS1=,_M;1O$MNJYE6
M1)(O]Y2Y_7D?C7J=<=X&T^\L9]7-U;2PB652A=<;AENGYBM3$YU]4_M:]\)3
M,VZ6.98I?]Y9%Y_$8/XU=\46\]W\0K*"VN&MIGA4+*O53\W-5IO#-_9>.87M
M[.9[$7L<RR*I*JI8$_3'3\*TO$MMJ</C6UU2STV:[2&)?N*<$_-QG\:`-2P\
M.ZY;7\$]QXBFGA1P7B(.''IUK/U8C3?B9I]V3B.YBVL??#+_`/$U;@\3:_)<
M11R>&9XT9P&<EOE!/)^[47C_`$J\OX;"XL8)99H78$1+D@'!S^:_K0!S,EN\
MW@FXU?&)FU/S]WMC'\S6_I\@U?XER72\QVUJ&4_50/\`V<U<BT68?#8Z<87^
MT&`OY>/FW[MX&/7H*K_#_2;RQ%]<7]O+%*^R-!(N#M`/_P!;\J`+>O>$8M6U
M`ZA87IM-07&XJ>"1P#QR#[UG6NOZ[H&LVVFZ_P"7/!.0J3KUY.,Y&,C/7(S3
M;FWU+POXMN]4MM/EO;*[R6$0)(+$$YP#@Y_`@TV>'5/&&O6$TFFS6-A:-N+3
M`@MR">N.N`..E`'H%>;:G%?S_$V9-,N4M[HH-LCJ"`/+&>"#VKTFN-73KS_A
M9S7WV:7[+Y>/.V_+_JP.OUH`P]2BU#3_`!)IDWBB47T);]TT+!54@CJNT>Q(
M[^M7/',4D_BO1H893#+)M5)!U0E\`_A5_P"(&F7E_%I[V=M+.8I'W"-<D`X_
MPJ#QA:ZA+X@TK4+*PGN5MPLA"H>H?=@^E`%ZU\-:]#=PRR^)9Y8TD5GC(;#@
M'D?>[UGS_P#)7;;_`*YG_P!%-5O_`(2GQ%_T*L__`'TW_P`35'6X-5L_'BZM
M9Z7/=QQQ@#:IPV4*GG'O0!W]>7:=IU]J7C#7(['4GL76>4LZ`_,/,/'!%=/8
M^(]<N;Z"&?PY-!$[A7E).$'KTK!M?[;T/Q/J]Y!HEQ=)<32!3@@8+D@@X-`'
M5Z'H^J:;=227VLR7T;)M5'!^4YZ\DURFE:YIW_"<:IJE_=+$@!B@W`G(R`",
M>R_K6ROB+7KB&XC?P]<0'R7*.-Q._'R\8]:B\(>%;>/1B^K:=&US)(2%GCRR
MJ.`.?H3^-`%+P/>P1^)M6LK:0/;3$RPL.A`;C]&_2M#5/!IN-2DU/1-1^R7;
M$LR@G:6/7D<C/<<U6O-$FTGQSI]]IE@_V-@!*(4^5,Y5LX]B#5:Q74_!>KWR
M#2Y[VQN6!1X03@`G'0'G!((-`%W1?$>KVFOIH>O(C2OQ',H`).,CIP0:QQ87
MFH_$'58;&_>RE`9C*H.2,KQP1ZC\JU+"SU/Q%XN@UJ\L9+*TME`C23(9L9QU
MQW.>E5776=(\:ZCJ5MH]Q=QR[D7"D`@X.0<'TH`Z/1M#U;3[_P`^]UR6\AV$
M>4P.,^O)-=#7,Z7X@UJ\U*&WNO#\UK`Y.Z9B<+P3Z>O%=-0`4444`%%%%`!1
M110!@ZKX4M-:DW7UY?2*&++&)0$7/H,4S2O!NF:/<R7%I)<B1XFBR9!P#W''
M7BNAHK'ZO2YN?EU[FWUBKR<BD[=CG+CP;:W<1BN=3U::,]4DNRP_(BIM,\'Z
M)I4JS06@>9>DDK%R#ZC/`/T%;M%"P])/FY5<;Q-9QY>9V"BBBMC`Y[5_"4&M
MOF^U+470,66)70(OT&S]3DU!I7@73='U&*]M;J]\V//#NA5@1@@C;TKJ**P>
M%I.?.XZ]SH6*K*'LU+3L<[%X.L[?>+6_U.V1F+>7!=%%&?0`58L_"FDVEU]J
M,+W-SG/G73F1L^O/&?>MJBJ5"DMHHEXBJ]')F=JND1ZO"8)KJZCA88:.%PH;
MZ\9K$A^'NCV\R30S7T<J'*NLP!!_*NLHI3H4IRYI1NPAB*M./+"5D1P1&&%8
MS*\I4??DQN/UP!4E%%;&(4444`%%%%`!1110`4444`%%%%`!1110`4444`%%
M%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`CJ'1E/1A@U7TZQA
MTRPALH"QBB7:NXY.*LT4K*]QW=K!1113$%%%%`!1110`4444`%%%%`!1110`
>4444`%%%%`!1110`4444`%%%%`!1110`4444`?_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
